Results 291 to 300 of about 109,588 (359)

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Enhancing Breast Reconstruction with Bovine Pericardium: A Preliminary STEP (Surgical Techniques and Efficacy in Pericardium Use) Towards Improved Outcomes. [PDF]

open access: yesJ Clin Med
Casella D   +9 more
europepmc   +1 more source

Mid-Term Experience With 1,196 Ozaki Procedures. [PDF]

open access: yesJACC Adv
Ozaki S   +13 more
europepmc   +1 more source

Case report and diagnostic implications of misdiagnosis of pericardial myxoid liposarcoma by multimodal imaging. [PDF]

open access: yesFront Cardiovasc Med
Wang J   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The Pediatric Pericardium

Radiology, 1974
In a review of 48 cases, pediatric pericardial abnormalities were categorized by etiology: developmental, tumor-related, pericarditic, and postsurgical. In 34 (70%) a pericardial effusion was present at some point in the clinical course; the plain film in these cases revealed that straightening of the left heart border is an early sign of fluid within ...
J L, Stolz, P, Borns, J, Schwade
openaire   +2 more sources

Home - About - Disclaimer - Privacy